STXS
Next earnings: Aug 6, 2026 · After close
Signal
Bearish Setup2
Price
1
Move-4.64%Selling pressure
Volume
1
Volume0.9× avgNormal activity
Technical
1
RSIRSI 43Momentum negative
PRICE
Prev Close
1.94
Open
1.92
Day Range1.85 – 1.99
1.85
1.99
52W Range1.74 – 3.59
1.74
3.59
6% of range
VOLUME & SIZE
Avg Volume
415.3K
FUNDAMENTALS
P/E Ratio
-7.7x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.43
Market-like
Performance
1D
-4.64%
5D
-2.63%
1M
-7.96%
3M
-7.04%
6M
-16.67%
YTD
-19.57%
1Y
-9.76%
Worst: YTD (-19.57%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +13% YoY · 54% gross margin
Valuation
FAIR
P/E not available
Health
MODERATE
CR 1.6 · FCF negative
Bullish
Key MetricsTTM
Market Cap$180.81M
Revenue TTM$31.20M
Net Income TTM-$21.68M
Free Cash Flow-$15.52M
Gross Margin53.9%
Net Margin-69.5%
Operating Margin-71.0%
Return on Equity-153.2%
Return on Assets-40.1%
Debt / Equity0.27
Current Ratio1.55
EPS TTM$-0.22

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
2 strong1 watch3 concern
38/100
Liquidity
1.55Watch
Leverage
0.27Strong
Coverage
0.0xConcern
ROE
-153.2%Concern
ROIC
-70.1%Concern
Cash
$13MStrong
ANALYST COVERAGE10 analysts
BUY
+89.2%upside to target
Buy
10100%
10 Buy (100%)0 Hold (0%)0 Sell (0%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
5/10
Technicals
RSI RangeRSI 43 — Bearish momentum
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 1.55 — healthy liquidity
Upcoming Events
EEarnings ReportMay 18, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 89 days
PDividend PaymentAug 20, 2026
In 95 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 21.3%

-2.8% vs SMA 50 · -23.5% vs SMA 200

Momentum

RSI42.5
Momentum fading
MACD-0.01
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$3.59+94.1%
EMA 200
$2.26+22.2%
EMA 50
$1.96+5.7%
Current
$1.85
52W Low
$1.74-5.9%
52-Week RangeNear 52-week low
$1.746th %ile$3.59
Squeeze SetupVolume-based
Distribution Pressure

Distribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.

20-Day Money Flow
Acc days:1
Dist days:4
Edge:+3 dist
Volume Context
Avg Vol (50D)419K
Recent Vol (5D)
447K+7%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 3 analysts
Analyst revisions:Revenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$23.7M
$22.8M$24.3M
-$0.27
±4%
Low2
FY2024
$27.2M
$26.8M$27.7M
+14.7%-$0.27
±6%
Moderate3
FY2025
$32.8M
$32.7M$32.8M
+20.4%-$0.24
±1%
Moderate3
Range confidence:Tight (high)ModerateWide (low)
Earnings HistorySTXS
Last 8Q
-5.0%avg beat
Beat 3 of 8 quartersMissed 3
-33%
Q3'24
-60%
Q4'24
-50%
Q1'25
Q2'25
+29%
Q3'25
+50%
Q4'25
Q1'26
+25%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Insider Activity
SEC Filings →
6 Buys/0 SellsNet Buying
Isaac Paul JDir
$45K
Nov 14
BUY
Isaac Paul JDir
$22K
Nov 17
BUY
Isaac Paul JDir
$69K
Mar 10
BUY
Isaac Paul JDir
$3K
Mar 7
BUY
Isaac Paul JDir
$42K
Mar 6
BUY
Isaac Paul JDir
$831
Aug 20
BUY
Financials

INSTITUTIONAL OWNERSHIP

1
DAFNA Capital Management LLC
13.7M
2
Lagoda Investment Management, L.P.
4.4M
3
BlackRock, Inc.
4.0M
4
Arbiter Partners Capital Management LLC
2.9M
5
GEODE CAPITAL MANAGEMENT, LLC
1.7M
6
ESSEX INVESTMENT MANAGEMENT CO LLC
1.6M
7
Archon Capital Management LLC
1.2M
8
Warberg Asset Management LLC
1.1M
News & Activity

STXS News

About

stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. these innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. over 100 issued patents support the stereotaxis platform. the core components of stereotaxis’ systems have received regulatory clearance in the united states, european union, japan, canada, china, and elsewhere. for more information, please visit www.stereotaxis.com.

Industry
Surgical and Medical Instrument Manufacturing
CEO
David Fischel
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
STXS
$1.85-4.64%$181M+2028.0%-6684.7%1500
$66.13-5.07%$13.0B+12626.1%-14525.8%1500
$94.92-3.79%$12.6B+3288.2%-4239.0%1500
$523.69-3.00%$12.1B+43205.3%-3008.0%1500
$227.72-1.30%$11.7B+6554.5%-2868.8%1500
$57.90-0.86%$11.2B50.3+1459.3%147.7%1500
$76.67-3.79%$10.8B+2325815.3%-19.7%1500
Sector avg-3.21%50.3+342139.5%-4456.9%1500